Tag: Chemotherapy
Chemo Ups Disease-Free Survival in Upper Tract Urothelial Cancer
Gemcitabine-platinum combination therapy tied to improved survival after nephroureterectomy
Adding Pembrolizumab May Up Response in Triple-Negative Breast Cancer
Pathological complete response rate higher with pembrolizumab plus neoadjuvant chemotherapy
Dasatinib Tops Imatinib for Ph+ Acute Lymphoblastic Leukemia
Four-year cumulative risk of any relapse lower for dasatinib in the context of intensive chemotherapy
One-Cycle BE500P Seems Safe for High-Risk Early Testicular Cancer
Malignant recurrence rate was 1.3 percent at two years for one-cycle BE500P in high-risk early-stage disease
Adverse Events Decreased With Proton Chemoradiotherapy
Relative risks lower for 90-day adverse events of at least grade 3 and 2 compared with photon therapy
Antioxidant, Supplement Use May Worsen Breast Cancer Outcomes
Disease-free, overall survival poorer with vitamin B12 use before and during chemotherapy
Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy
Obesity independently associated with treatment-related cardiotoxicity in breast cancer patients
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC
Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL
Most patients had negative PET scan and completed one additional R-CHOP cycle without radiation
